Favorability *******
***** *** ********* *** ********* ***** integrators, ********* **** *** ******** *** negative ***** *** ********, **** **% of *********** *** ******* ****** ** give ** *******.
***** ** ***** ** ******* ******* the ** ** ** *** **, 93% **. **%, **** ******** *** negative ***** ***** *** ****, ** well. ***** ******* **, *** *** focused ** *** **.
Most ***********: Don't ****
**** *********** *** *** **** *** Flock *** ** *** ** *******, with **** * ******* ** ******** and ******** *****.
"** *** **** ****** ***** *** company ** ******* ** ******** *******." "* **** **** **** ****** **** but **** ** ***** **** ********** with ****. *** ******* ***** ***** seems **** ********** *** **** **** offer, *** ** ****** ********." "***** ***** ** **** ***** ***. Even ***** ******* ***** ** ** they **** **** *** **** ** product. *** *** ***** ****** *********? Just *** ***********?" "***** ***** ***** ***" "***'* **** ** *** **** ****** to **** ** *******." "***'* **** ******** ***** ****" "* **** ** ****** ********** **** it, ** ***** ** *******" "**** ***** ****'* **** ** *** radar *** **** ** **********" "* ** *** **** **** *****." "***** ***** ** **** ***** ** singapore"
"***** ****** **** **** *****" "** ****, * ** *** **** the *****" "*** ******** **** *** *****" "**** ***** ****'* **** ** *** radar *** **** ** **********" "** **** *** **** **** ***** in *** *************." "*******" "******* - ***** ***** ** ****" "***?" Negative: *** **** ** ***********
*** *********** ********* *****'* ****** ***** model, **** ** ********** *******, ** a ********.
"** *** *** *********** ** ******* with ****. **** **** * **** niche ******, *** **** **** ******* to **** *********** *** **** ***** sub *********** **** ** *** ****." "***** **** **** *** ***** ****, but *** *** *** ******** *******. They ** ****** ** *** **** no ****** **** **** ***** ** opening ** ** ***********." Positive: *********** *****
***** *** *********** **** * ********* view *** ***** ** ****** ** interesting *****.
"**** *****, ******** ********* ******, ********** for ***********, **********, ***** ******. **** to ******, **** ** **********. *********** is '*** ***' ** '******' *** which ****** **** *-* * **** per **** ********. ***: ******* ** can ** ****** **********. ****** ** expensive, *** ** ******** **********, **** acceptable ** ****** *********** *** *** in **** ***** *****." "***** ** **** *** ***** ***********, but *** *** ******** **** ***** prices."
"*********** *****; ******* ** ************* ** most ** *** *******. * **** really *** ***** **** ***** **** in *** ******." *******
*****'* **** ** *********** ***** *********** is ************, ***** ***** ****** ***** strategy ************** **** **** **** *** ***** Axon , **** ** ***** ** ********* an ********** *******. ****** ******** **** channel *** ******* ******** *****, ***** has ** *** **** ********** ******* funds ***** ** ***** ******* *****. We ****** ********* ********, ***** ********** ***** ***** ******* to ***** ***** ***, **** ******* drive *****.
*** ********** *** ***** ************ ***** makes ***** * ******* ****** ** monitored *** ****** ******. ***** **** may ** ******* ***, ***** ***** gives **** *** *********** ** ****** a ***** ****** ******* / ************ ********* ******** ** grow .
Comments (0)